基石藥業與Istituto Gentili達成獨家戰略合作
基石藥業-B(2616)公布,與Istituto Gentili就舒格利單抗在西歐和英國達成獨家戰略合作。
Last Update:
8 7 月, 2025
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.